“In-Silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues As Dual Inhibitors Targeting Breast Cancer”. Asian Journal of Pharmaceutical and Health Sciences, vol. 11, no. 2, June 2021, pp. 2468-74, https://doi.org/10.5530/qsrddd17.